|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.98 USD | -1.12% |
|
+3.57% | +9.07% |
Company Valuation: The Clorox Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 22,376 | 17,352 | 19,661 | 16,948 | 14,799 | 13,415 | - | - |
| Change | - | -22.45% | 13.31% | -13.8% | -12.68% | -9.35% | - | - |
| Enterprise Value (EV) 1 | 24,841 | 19,880 | 21,821 | 19,231 | 17,120 | 16,442 | 16,479 | 16,306 |
| Change | - | -19.97% | 9.77% | -11.87% | -10.98% | -3.96% | 0.22% | -1.05% |
| P/E ratio | 32.2x | 37.8x | 133x | 60.7x | 18.4x | 19.3x | 17.2x | 16x |
| PBR | 53.9x | 31.2x | 89.5x | 51.7x | 45.9x | 74x | 30.2x | 24x |
| PEG | - | -1.1x | -2x | 0.7x | 0x | -1.5x | 1.4x | 2.1x |
| Capitalization / Revenue | 3.05x | 2.44x | 2.66x | 2.39x | 2.08x | 2.07x | 1.98x | 1.92x |
| EV / Revenue | 3.38x | 2.8x | 2.95x | 2.71x | 2.41x | 2.53x | 2.43x | 2.33x |
| EV / EBITDA | 16.9x | 20.4x | 18.9x | 15x | 11.2x | 13x | 11.8x | 11.2x |
| EV / EBIT | 19.8x | 26.5x | 23.8x | 18.4x | 13x | 15.6x | 13.9x | 13.1x |
| EV / FCF | 26.3x | 37.2x | 23.5x | 39.8x | 22.5x | 28.4x | 19.8x | 18.1x |
| FCF Yield | 3.8% | 2.69% | 4.26% | 2.51% | 4.45% | 3.52% | 5.04% | 5.51% |
| Dividend per Share 2 | 4.49 | 4.66 | 4.72 | 4.8 | 4.88 | 4.937 | 5.203 | 5.276 |
| Rate of return | 2.5% | 3.31% | 2.97% | 3.52% | 4.06% | 4.49% | 4.73% | 4.8% |
| EPS 2 | 5.58 | 3.73 | 1.2 | 2.25 | 6.52 | 5.693 | 6.396 | 6.883 |
| Distribution rate | 80.5% | 125% | 393% | 213% | 74.8% | 86.7% | 81.3% | 76.6% |
| Net sales 1 | 7,341 | 7,107 | 7,389 | 7,093 | 7,104 | 6,486 | 6,792 | 6,992 |
| EBITDA 1 | 1,467 | 974 | 1,153 | 1,280 | 1,535 | 1,267 | 1,400 | 1,458 |
| EBIT 1 | 1,256 | 750 | 917 | 1,045 | 1,316 | 1,051 | 1,184 | 1,246 |
| Net income 1 | 710 | 462 | 149 | 280 | 810 | 702.2 | 793.8 | 845.8 |
| Net Debt 1 | 2,465 | 2,528 | 2,160 | 2,283 | 2,321 | 3,027 | 3,063 | 2,891 |
| Reference price 2 | 179.91 | 140.98 | 159.04 | 136.47 | 120.07 | 109.98 | 109.98 | 109.98 |
| Nbr of stocks (in thousands) | 124,372 | 123,080 | 123,624 | 124,188 | 123,253 | 121,980 | - | - |
| Announcement Date | 8/3/21 | 8/3/22 | 8/2/23 | 8/1/24 | 7/31/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.32x | 2.53x | 12.98x | 4.49% | 13.42B | ||
| 21.18x | 3.41x | 12.29x | 3.45% | 55B | ||
| 27.36x | 3.8x | 16.74x | 1.31% | 21.76B | ||
| 21.64x | 2.57x | 14.17x | 4.05% | 5.51B | ||
| 16.46x | 1.77x | 9.83x | 3.83% | 5.03B | ||
| 17.77x | 0.86x | 6.82x | 1.79% | 2.93B | ||
| 33.63x | 4.3x | 22.71x | - | 2.76B | ||
| 25.72x | 2.95x | 18.12x | 1.78% | 1.03B | ||
| Average | 22.89x | 2.78x | 14.21x | 2.96% | 13.43B | |
| Weighted average by Cap. | 22.27x | 3.21x | 13.43x | 3.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CLX Stock
- Valuation The Clorox Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















